Background. Intradialytic hypotension is a clinically significant problem, however, the hemodynamics that underlie ultrafiltration and consequent hypotensive episodes has not been studied comprehensively. Methods. Intradialytic cardiac output, cardiac power and peripheral resistance changes from pretreatment measurements were evaluated using a novel regional impedance cardiographic device (NICaS, NI Medical, Peta Tikva, Israel) in 263 hemodialysis sessions in 54 patients in dialysis units in the USA and Brazil with the goal of determining the various hemodynamic trends as blood pressure decreases. 
A B S T R A C T
Background. Intradialytic hypotension is a clinically significant problem, however, the hemodynamics that underlie ultrafiltration and consequent hypotensive episodes has not been studied comprehensively. Methods. Intradialytic cardiac output, cardiac power and peripheral resistance changes from pretreatment measurements were evaluated using a novel regional impedance cardiographic device (NICaS, NI Medical, Peta Tikva, Israel) in 263 hemodialysis sessions in 54 patients in dialysis units in the USA and Brazil with the goal of determining the various hemodynamic trends as blood pressure decreases. Conclusions. The hemodynamic profiles clearly define specific hemodynamic mechanisms of cardiac power reduction and/or vasodilatation as underlying intradialytic hypotensive episodes. A reduction in cardiac power (reduction of both blood pressure and cardiac output) could be the result of preload reduction due to a high ultrafiltration rate with not enough refilling or low target weight. A reduction in peripheral resistance (reduction in blood pressure and increase in cardiac output) could be the result of relative vasodilatation as arteries do not contract to compensate for volume reduction due to autonomous dysfunction. As both phenomena are independent, they may appear at the same time. Based on these results, a reduction of ultrafiltration rate and an increase in target weight to improve preload or immediate therapeutic actions to increase peripheral resistance are rational measures that could be taken to maintain blood pressure and prevent hypotensive ischemic complications in dialysis patients.
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I N T R O D U C T I O N
Hypotension occurring during chronic hemodialysis is a major clinical problem with consequent ischemia of the heart, brain and gut [1] . Reduced cardiac preload due to hypovolemia may be further diminished in the presence of diastolic dysfunction [2] . An increase in sympathetic tone may add functional problems [3] . These factors are associated with an increase in mortality in hemodialysis patients [4] . The hemodynamics underlying ultrafiltration and consequent hypotensive episodes have not been studied comprehensively. Zucchelli and Santoro in 1993 [5] suggested that intradialytic hypotensive episodes may be the result of hypovolemia, left ventricular diastolic dysfunction or a 'breakdown' in peripheral resistance, but they did not provide data showing intradialytic hemodynamic trends. The objective of this study is to report the hemodynamic changes during hemodialysis, specifically focusing on those responsible for intradialytic hypotensive episodes. All hemodynamic measurements were made using a regional impedance cardiography device (NICaS, NI Medical, Peta Tikva, Israel), which have been shown to correlate well with pulmonary artery catheterization thermodilution and echocardiographic data [6] [7] [8] and are more accurate than thoracic impedance cardiographic measurements [9] . The accuracy of the device during dialysis has been recently validated, demonstrating a strong correlation of stroke volume (SV) with echocardiographic measurements, with insignificant bias [10] .
M A T E R I A L S A N D M E T H O D S

Patients
Fifty-four established chronic hemodialysis patients at the Queens Artificial Kidney Center, New York (n ¼ 26) and at the Biocor Hospital, Belo Horizonte, Brazil (n ¼ 28) were studied. Patients were randomly selected. There were no inclusion criteria other than dialysis vintage of at least 3 months. All gave written informed consent. The study was approved by the New England Institutional Review Board (IRB) and by the Biocor Hospital de Doencas Cardiovasculares, Belo Horizonte IRB.
Study protocol
Hemodynamic trends were assessed using the device in randomly selected dialysis sessions. Sitting blood pressures were measured immediately prior to each hemodynamic measurement. Gender, age, height, weight, electrode location and blood pressure data were entered into the device. The device measures and calculates hemodynamic parameters on each heart beat during 60 s and provides the averaged parameters. Each patient's hemodynamics were measured over a range of dialysis treatments with an average of 4.9 6 2.3 treatments per patient. Measurements were made at baseline (pretreatment), at the middle, just before the end and 10 min after the end of the treatment. The dialysis staff was blinded to all measurements derived from the device.
Technology used for hemodynamic measurements
The device (NICaS, NI Medical) is a noninvasive regional bioimpedance cardiac measurement and analysis system (FDA 510k clearance no. K080941, 12 June 2009). The US Food and Drug Administration indication for use of the device states 'NICaS is intended to monitor and display hemodynamic parameters in males and females with known or suspected cardiac disorders needing cardiac assessment'. SV is measured by applying an alternating electrical current of 1.4 mA at 30 kHz frequency through the patient's body via two pairs of tetrapolar sensors, one pair placed on the wrist of the nonaccess arm above the radial pulse and the other pair on the contralateral ankle above the posterior tibial pulse (Figure 1 ). SV is calculated by Frinerman's formula: [2] [3] [4] , where dR is the impedance change in the arterial system as a result of intraarterial expansion during systole, R is basal resistance, q is blood electrical resistance, L is the patient's height, Ri is basal resistance corrected for gender and age, KW is the correction of weight according to ideal values, HF is a hydration factor that takes into account the ratio between R and body mass index (BMI), which is correlated to body water volume, a þ b is the electrocardiogram (ECG) R-R wave interval and b is the diastolic time interval. SV is automatically calculated every 20 s and is the average of three measurements obtained consecutively during 60 s of monitoring. The SV index is calculated as SV/body surface area using the Du Bois formula [11] . Heart rate is calculated from a one channel ECG and cardiac (output) index ¼ SV index Â heart rate/1000.
Using an oscillometric method, sitting systolic and diastolic blood pressure measurements were made automatically by the dialysis machine. Mean arterial pressure [ [13] were calculated. As the device measures pulsatile flow and is blinded to constant flow, fluid removal during dialysis has no impact on measurement accuracy. This was recently validated by correlating SV to ECG measurements during hemodialysis treatments. Good correlation was maintained during treatment. Further, NICaS performance immunity to fluid reduction was demonstrated by the maintenance of correlation to ECG results throughout dialysis treatments [10] .
The results are drawn on hemodynamic graphs showing the MAP (y-axis) as a function of cardiac index (x-axis); curves of total peripheral resistance index (TPRI) and CPI are displayed. Ranges for the normal population are depicted by the dotted octagon ( Figure 2 ).
Statistical analysis
The Kolmogorov-Smirnov test for normally distributed data was used. Descriptive statistics are presented as number (percentages) and mean 6 SD. The comparisons for each parameter between the pretreatment and the intra-and postdialytic measurements were made according to the occurrence of intradialytic hypotension (IDH) episodes and by IDH subgroups related to specific hemodynamic changes. Since each evaluation was not only influenced by individual cardiovascular functional responses but also by sodium intake between dialysis and dialysis treatment variables, such as target weight, fluid removal rates and dialysate temperatures, each patient was measured during a few dialysis treatments and analysis of all comparisons was performed using a mixed model for repeated measurements [14] employing a mixed procedure (SAS/STAT software, version 9.4; SAS Institute, Cary, NC, USA) and adjusted for multiple comparisons using the Tukey-Kramer method [15] . Results are presented as mean and 95% confidence intervals (CIs). P-values 0.05 were considered to be significant.
R E S U L T S : N O N -I D H A N D T H R E E I D H S U B G R O U P S
Fifty-four patients from two sites in the USA and Brazil were studied. The composition of the study group included 29 males (54%), mean age 67 6 10 years, mean weight 74 6 17 kg, mean BMI 27.6 6 5.2 and 30 diabetic patients (56% FIGURE 1: ECG waveform and impedance waveform (left). Sensor locations (right). An alternating electrical current of 1.4 mA at 30 kHz frequency is applied through the patient's body via two pairs of tetrapolar sensors. The impedance waveform provides the changes in electrical resistivity of the arterial system with each heartbeat. SV is calculated based on these changes. Heart rate (HR) is measured by the ECG that is sensed through the same sensors. Cardiac output (CO) is calculated as CO ¼ SVÂHR. Criteria
episode in at least 30% of dialysis treatments were defined as having IDH.
In a total of 263 treatments, 736 intra-and postdialytic measurements were evaluated for IDH episodes by comparing them with the relevant predialytic measurements. A total of 99 (13.5%) evaluations met the criteria for IDH. Fourteen (26%) patients were categorized as having IDH. The demographics of the IDH and non-IDH patients did not differ significantly (Table 1) . IDH episodes were recorded in 61 (23.2%) of 263 treatments. In this latter group, pretreatment hemodynamics, fluid removal rates, total fluid removed and duration of treatments did not significantly differ from non-IDH treatments ( Table 2 ).
In (Table 3) .
Since the primary objective of the study was to categorize IDH episodes in terms of the immediate hemodynamic cause(s) of hypotension, and not a comparison of individual patients, the episodes (n ¼ 99) were divided into three subgroups according to the observed functional changes per episode. The three subgroups were initially defined according to changes in cardiac output (decrease, increase or no change) as blood pressure decreased. As cardiac power is the product of blood pressure and cardiac output, a reduction in either or both will reduce cardiac power. Since peripheral resistance is the ratio between blood pressure and cardiac output, cardiac output will decrease as a result of a decrease in peripheral resistance. As a result, the three subgroups where named as follows:
1. Predominantly due to CPI decrease: defined as a CPI decrease >15% and a CI decrease >5%. Differences in changes in CI, CPI and TPRI between IDH subgroups 1 and 2 were significant: P < 0.001 for changes in CI and CPI and P ¼ 0.002 for changes in TPRI. Differences in changes in SBP and MAP between IDH subgroups 1 and 2 were not significant (P ¼ 0.67 and 0.99, respectively). Table 3 shows the hemodynamic trends of the non-IDH and the three IDH subgroups. Figure 2 illustrates the hemodynamic trends of each individual evaluation in the three IDH subgroups using three hemodynamic graphs of MAP versus CI. Representative lines of both CPI and TPRI are also shown. Hemodynamic ranges for a normal population are illustrated by a dashed octagon. Each arrow provides the MAP and CI changes from pretreatment of all intra-and postdialytic evaluations, which are substantial reductions of CPI and CI for subgroup 1, a substantial reduction of TPRI and an increase of CI in subgroup 2 and substantial reductions of both CPI and TPRI with no change of CI in subgroup 3.
D I S C U S S I O N
The clinically vital relationship between intradialytic hypotension and consequent morbidity and mortality is unquestioned [16, 17] .
The primary objective of this article was to report changes of cardiac output, peripheral resistance and cardiac power during incidents of IDH. The stringent definition of IDH used here includes a nadir SBP <100 mmHg or a nadir MAP <70 mmHg and was used to compensate for the lack of information about intradialytic symptoms, which is included in some definitions of IDH as additional subjective criteria.
This study utilized regional impedance cardiographic technology, which has been validated for measurements during chronic hemodialysis [10] . It measures cardiac output, and with the additional information of blood pressure, calculates cardiac power and total peripheral resistance. All parameters were indexed to body surface area.
Cardiac power reduction may occur as a result of a preload reduction due to high ultrafiltration rates with inadequate vascular refilling or a low target weight, together resulting in hypovolemia and a consequent reduction in blood pressure and cardiac output. Hemodynamic data are shown as adjusted mean (95% CI).
a All hemodynamic data and P-values were calculated using a mixed model for repeated measurements and adjusted for multiple comparisons using the Tukey-Kramer method. Adj., adjusted; Pre, pretreatment; TPRI, total peripheral resistance index (dyn Â s/cm 5 Â m
The presence of diastolic dysfunction may increase cardiac sensitivity to preload reduction [18] . Low cardiac power has been shown to be an independent predictor of inhospital mortality in a broad spectrum of patients with primary cardiac disease [12] . As total peripheral resistance is the ratio between blood pressure and cardiac output, a reduction of blood pressure and an increase in cardiac output are the result of a reduction in total peripheral resistance. Such a reduction could be the result of volume reduction without compensatory vasoconstriction, which creates a situation of relative vasodilatation. Autonomic dysfunction, often associated with diabetes, could be the underlying reason for failure of vasoconstriction. Low peripheral resistance has been shown to be an independent predictor of inhospital mortality in both sepsis and nonseptic patients [19] As hypovolemia (preload reduction) and autonomous dysfunction are independent parameters, both may occur in the same patient during the same dialysis, resulting in unchanged cardiac output. This means that both cardiac power and peripheral resistance may decrease at the same time.
The new ability to categorize the underlying hemodynamic abnormalities leading to IDH in each patient and each dialysis session provides significant potential to improve the management of hypotension.
A reduction of the ultrafiltration rate or an increase in the prescribed target weight in response to a progressive decrease in cardiac power or by the use of short-acting alpha adrenergic agonists, such as midodrine, in the prophylaxis or treatment of peripheral resistance decrease [20] are rational interventions that could reduce intradialytic episodes and prevent organ ischemia and consequent damage.
The unexpected relatively high frequency of vasodilatation as a direct cause of hypotensive episodes either alone or together with decreased cardiac power (collectively 64.7% of all IDH episodes) suggests that more emphasis might be placed on autonomic dysfunctional disorders, particularly in patients with diabetes. The similarity in pretreatment hemodynamics in the IDH and non-IDH groups increases the value of intradialytic characterization of IDH mechanisms for appropriate interventions.
Limitations
The number of patients studied was small. However, the emphasis of this article is the analysis of all hemodynamic responses occurring during each dialysis, not a comparison of individual patients. Measurements were not made continuously and therefore IDH episodes occurring earlier in treatments would have been missed; however, the hemodynamics of every recorded IDH episode were analyzed. Comorbid and cardiovascular status data and information on inter-and intradialytic drug use were not collected since the main purpose of this study was to characterize IDH episodes in the course of routine dialysis treatments. An increase in the accuracy of blood pressure measurements would improve interpretation of small changes in hemodynamics.
In conclusion, intradialytic noninvasive cardiac output measurement has enabled the assessment of changes in cardiac power and peripheral resistance. These have been demonstrated to be distinctly different causes of hypotensive episodes in routine dialysis patients. This information can potentially improve the care of dialysis patients prone to IDH, by interventions based on specific cause.
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